Atara Biotherapeutics Archives -

Atara Biotherapeutics has become the first biotech to win regulatory approval for a T-cell therapy based on donated

Atara claims first world approval for off-the-shelf T-cell therapy

https://pharmaphorum.com/news/atara-claims-first-world-approval-for-off-the-shelf-t-cell-therapy/

Market Access/ News/ News/ News/ Oncology

Atara closes on first approval of transplant complication therapy

Phil Taylor allogeneic, Atara Biotherapeutics, cell therapy, Ebvallo, immuno-oncology, Oncology, Pierre Fabre, tabelecleucel 0 Comment

Atara Biotherapeutics’ cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according

Atara closes on first approval of transplant complication therapy

https://pharmaphorum.com/news/atara-closes-on-first-approval-of-transplant-complication-therapy/

News/ News/ News/ Oncology/ R&D

Bayer bails on $670m CAR-T partnership with Atara

Phil Taylor Atara Biotherapeutics, Bayer, CAR-T therapies, immuno-oncology, Oncology, partnering 0 Comment

In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a

Bayer bails on $670m CAR-T partnership with Atara

https://pharmaphorum.com/news/bayer-bails-on-670m-car-t-partnership-with-atara/

Trending

Atara Biotherapeutics

Login